2023. Corrigendum: IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation. Biomolecules and Biomedicine. 23, 3 (May 2023), 545. DOI:https://doi.org/10.17305/bb.2022.8739.